Achieve Life grants director options and RSUs
Achieve Life Sciences director Thomas Sellig received equity awards comprising 25,000 stock options with an exercise price of $6.18 per share and 16,700 restricted stock units (RSUs), each RSU representing one share of common stock.
Rhea-AI Filing Summary
Achieve Life Sciences director Thomas Sellig received equity awards comprising 25,000 stock options with an exercise price of $6.18 per share and 16,700 restricted stock units (RSUs), each RSU representing one share of common stock.
Both the options and RSUs vest 100% on the earlier of July 27, 2027 or the date immediately prior to Achieve Life Sciences’ 2027 annual meeting of stockholders, contingent on his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 41,700 shares
Grant/Award
2 txns
Insider
Sellig Thomas
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 25,000 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit (RSU) F2, F3 | 16,700 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 25,000 contracts (Direct);
Restricted Stock Unit (RSU) — 16,700 contracts (Direct)
Footnotes (3)
- F1. The options vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
- F2. Each RSU represents a contingent right to receive one share of the Issuer's common stock at settlement.
- F3. Pursuant to the terms of the RSU, the shares underlying the RSU vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date.
Key Figures
Stock options granted: 25000.0000 shares
Option exercise price: $6.1800 per share
Option expiration date: July 27, 2036
+2 more
5 metrics
Stock options granted
25000.0000 shares
Options to purchase Achieve Life Sciences common stock granted to director Thomas Sellig
Option exercise price
$6.1800 per share
Exercise price for stock options granted on July 27, 2026
Option expiration date
July 27, 2036
Expiration date of stock options awarded to Thomas Sellig
RSUs granted
16700.0000 units
Restricted Stock Units representing Achieve Life Sciences common stock granted to Thomas Sellig
Vesting trigger date
July 27, 2027
Earlier of this date or immediately prior to 2027 annual meeting, subject to continued service
Key Terms
Stock Option (right to buy), Restricted Stock Unit (RSU), vesting, exercise price, +1 more
5 terms
Stock Option (right to buy) financial
"Stock Option (right to buy) with an exercise price of $6.18 per share"
Restricted Stock Unit (RSU) financial
"Restricted Stock Unit (RSU) represents a contingent right to receive one share"
A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.
vesting financial
"The options and RSUs vest 100% on the earlier of July 27, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"Exercise price of $6.18 per share applies to the stock options granted"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
annual meeting of stockholders regulatory
"Awards vest on the earlier of July 27, 2027 or immediately prior to the 2027 annual meeting of stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Achieve Life Sciences (ACHV) grant to director Thomas Sellig?
Thomas Sellig received 25,000 stock options with a $6.18 exercise price and 16,700 RSUs. Each RSU corresponds to one share of common stock, providing a mix of options and full-value share units as part of his director compensation.
What are the vesting terms of the new equity awards for ACHV director Thomas Sellig?
Both the 25,000 options and 16,700 RSUs vest 100% on the earlier of July 27, 2027 or the date immediately before Achieve Life Sciences’ 2027 annual meeting, provided Sellig continues to serve the company through the vesting date.
What is the exercise price and expiration date of the stock options granted by ACHV?
The stock options granted to Thomas Sellig have an exercise price of $6.18 per share and an expiration date of July 27, 2036. He can purchase common stock at this price once the options vest and before they expire.
Are the reported ACHV equity grants to Thomas Sellig under a Rule 10b5-1 trading plan?
The equity awards are not indicated as made under a Rule 10b5-1 trading plan. The Rule 10b5-1 checkbox is shown as unchecked, and the footnotes describe vesting terms but do not reference any pre-arranged trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
